Global HER2 ADC Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global HER2 ADC Drugs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
The HER2-targeted antibody–drug conjugates (ADCs) trastuzumab emtansine (T-DM1) and trastuzumab deruxtecan (T-DXd) represent a novel class of therapeutics in breast cancer. These drugs augment monoclonal antibodies with a cytotoxic payload, which is attached by a linker, forming the basic structure of an ADC.
This report is a detailed and comprehensive analysis for global HER2 ADC Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
The HER2-targeted antibody–drug conjugates (ADCs) trastuzumab emtansine (T-DM1) and trastuzumab deruxtecan (T-DXd) represent a novel class of therapeutics in breast cancer. These drugs augment monoclonal antibodies with a cytotoxic payload, which is attached by a linker, forming the basic structure of an ADC.
This report is a detailed and comprehensive analysis for global HER2 ADC Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
- Global HER2 ADC Drugs market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
- Global HER2 ADC Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
- Global HER2 ADC Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
- Global HER2 ADC Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for HER2 ADC Drugs
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
- This report profiles key players in the global HER2 ADC Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Daiichi Sankyo, Genentech, Inc.(Roche), AstraZeneca, RemeGen, MacroGenics, Takeda, Biokin Pharmaceutical, BioNTech(Yingen Biopharmaceutical), CSPC Pharmaceutical Group, Hengrui Pharmaceuticals, etc.
- This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
HER2 ADC Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- T-DM1?Kadcyla?Trastuzumab emtansine?
- T-DXd?DS-8201?Enhertu?Trastuzumab deruxtecan?
- RC48?Disitamab vedotin?
Market segment by Application
- Hospitals
- Clinic
- Others
Major players covered
- Daiichi Sankyo
- Genentech, Inc.(Roche)
- AstraZeneca
- RemeGen
- MacroGenics
- Takeda
- Biokin Pharmaceutical
- BioNTech(Yingen Biopharmaceutical)
- CSPC Pharmaceutical Group
- Hengrui Pharmaceuticals
Market segment by region, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
- Chapter 1, to describe HER2 ADC Drugs product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top manufacturers of HER2 ADC Drugs, with price, sales quantity, revenue, and global market share of HER2 ADC Drugs from 2021 to 2026.
- Chapter 3, the HER2 ADC Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Chapter 4, the HER2 ADC Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
- Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and HER2 ADC Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
- Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
- Chapter 13, the key raw materials and key suppliers, and industry chain of HER2 ADC Drugs.
- Chapter 14 and 15, to describe HER2 ADC Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global HER2 ADC Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 T-DM1?Kadcyla?Trastuzumab emtansine?
1.3.3 T-DXd?DS-8201?Enhertu?Trastuzumab deruxtecan?
1.3.4 RC48?Disitamab vedotin?
1.4 Market Analysis by Application
1.4.1 Overview: Global HER2 ADC Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospitals
1.4.3 Clinic
1.4.4 Others
1.5 Global HER2 ADC Drugs Market Size & Forecast
1.5.1 Global HER2 ADC Drugs Consumption Value (2021 & 2025 & 2032)
1.5.2 Global HER2 ADC Drugs Sales Quantity (2021-2032)
1.5.3 Global HER2 ADC Drugs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Daiichi Sankyo
2.1.1 Daiichi Sankyo Details
2.1.2 Daiichi Sankyo Major Business
2.1.3 Daiichi Sankyo HER2 ADC Drugs Product and Services
2.1.4 Daiichi Sankyo HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Daiichi Sankyo Recent Developments/Updates
2.2 Genentech, Inc.(Roche)
2.2.1 Genentech, Inc.(Roche) Details
2.2.2 Genentech, Inc.(Roche) Major Business
2.2.3 Genentech, Inc.(Roche) HER2 ADC Drugs Product and Services
2.2.4 Genentech, Inc.(Roche) HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Genentech, Inc.(Roche) Recent Developments/Updates
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca HER2 ADC Drugs Product and Services
2.3.4 AstraZeneca HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 AstraZeneca Recent Developments/Updates
2.4 RemeGen
2.4.1 RemeGen Details
2.4.2 RemeGen Major Business
2.4.3 RemeGen HER2 ADC Drugs Product and Services
2.4.4 RemeGen HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 RemeGen Recent Developments/Updates
2.5 MacroGenics
2.5.1 MacroGenics Details
2.5.2 MacroGenics Major Business
2.5.3 MacroGenics HER2 ADC Drugs Product and Services
2.5.4 MacroGenics HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 MacroGenics Recent Developments/Updates
2.6 Takeda
2.6.1 Takeda Details
2.6.2 Takeda Major Business
2.6.3 Takeda HER2 ADC Drugs Product and Services
2.6.4 Takeda HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Takeda Recent Developments/Updates
2.7 Biokin Pharmaceutical
2.7.1 Biokin Pharmaceutical Details
2.7.2 Biokin Pharmaceutical Major Business
2.7.3 Biokin Pharmaceutical HER2 ADC Drugs Product and Services
2.7.4 Biokin Pharmaceutical HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Biokin Pharmaceutical Recent Developments/Updates
2.8 BioNTech(Yingen Biopharmaceutical)
2.8.1 BioNTech(Yingen Biopharmaceutical) Details
2.8.2 BioNTech(Yingen Biopharmaceutical) Major Business
2.8.3 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product and Services
2.8.4 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 BioNTech(Yingen Biopharmaceutical) Recent Developments/Updates
2.9 CSPC Pharmaceutical Group
2.9.1 CSPC Pharmaceutical Group Details
2.9.2 CSPC Pharmaceutical Group Major Business
2.9.3 CSPC Pharmaceutical Group HER2 ADC Drugs Product and Services
2.9.4 CSPC Pharmaceutical Group HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 CSPC Pharmaceutical Group Recent Developments/Updates
2.10 Hengrui Pharmaceuticals
2.10.1 Hengrui Pharmaceuticals Details
2.10.2 Hengrui Pharmaceuticals Major Business
2.10.3 Hengrui Pharmaceuticals HER2 ADC Drugs Product and Services
2.10.4 Hengrui Pharmaceuticals HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Hengrui Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HER2 ADC DRUGS BY MANUFACTURER
3.1 Global HER2 ADC Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global HER2 ADC Drugs Revenue by Manufacturer (2021-2026)
3.3 Global HER2 ADC Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of HER2 ADC Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 HER2 ADC Drugs Manufacturer Market Share in 2025
3.4.3 Top 6 HER2 ADC Drugs Manufacturer Market Share in 2025
3.5 HER2 ADC Drugs Market: Overall Company Footprint Analysis
3.5.1 HER2 ADC Drugs Market: Region Footprint
3.5.2 HER2 ADC Drugs Market: Company Product Type Footprint
3.5.3 HER2 ADC Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global HER2 ADC Drugs Market Size by Region
4.1.1 Global HER2 ADC Drugs Sales Quantity by Region (2021-2032)
4.1.2 Global HER2 ADC Drugs Consumption Value by Region (2021-2032)
4.1.3 Global HER2 ADC Drugs Average Price by Region (2021-2032)
4.2 North America HER2 ADC Drugs Consumption Value (2021-2032)
4.3 Europe HER2 ADC Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific HER2 ADC Drugs Consumption Value (2021-2032)
4.5 South America HER2 ADC Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa HER2 ADC Drugs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global HER2 ADC Drugs Sales Quantity by Type (2021-2032)
5.2 Global HER2 ADC Drugs Consumption Value by Type (2021-2032)
5.3 Global HER2 ADC Drugs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global HER2 ADC Drugs Sales Quantity by Application (2021-2032)
6.2 Global HER2 ADC Drugs Consumption Value by Application (2021-2032)
6.3 Global HER2 ADC Drugs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America HER2 ADC Drugs Sales Quantity by Type (2021-2032)
7.2 North America HER2 ADC Drugs Sales Quantity by Application (2021-2032)
7.3 North America HER2 ADC Drugs Market Size by Country
7.3.1 North America HER2 ADC Drugs Sales Quantity by Country (2021-2032)
7.3.2 North America HER2 ADC Drugs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe HER2 ADC Drugs Sales Quantity by Type (2021-2032)
8.2 Europe HER2 ADC Drugs Sales Quantity by Application (2021-2032)
8.3 Europe HER2 ADC Drugs Market Size by Country
8.3.1 Europe HER2 ADC Drugs Sales Quantity by Country (2021-2032)
8.3.2 Europe HER2 ADC Drugs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific HER2 ADC Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific HER2 ADC Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific HER2 ADC Drugs Market Size by Region
9.3.1 Asia-Pacific HER2 ADC Drugs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific HER2 ADC Drugs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America HER2 ADC Drugs Sales Quantity by Type (2021-2032)
10.2 South America HER2 ADC Drugs Sales Quantity by Application (2021-2032)
10.3 South America HER2 ADC Drugs Market Size by Country
10.3.1 South America HER2 ADC Drugs Sales Quantity by Country (2021-2032)
10.3.2 South America HER2 ADC Drugs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa HER2 ADC Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa HER2 ADC Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa HER2 ADC Drugs Market Size by Country
11.3.1 Middle East & Africa HER2 ADC Drugs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa HER2 ADC Drugs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 HER2 ADC Drugs Market Drivers
12.2 HER2 ADC Drugs Market Restraints
12.3 HER2 ADC Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of HER2 ADC Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of HER2 ADC Drugs
13.3 HER2 ADC Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 HER2 ADC Drugs Typical Distributors
14.3 HER2 ADC Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global HER2 ADC Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 T-DM1?Kadcyla?Trastuzumab emtansine?
1.3.3 T-DXd?DS-8201?Enhertu?Trastuzumab deruxtecan?
1.3.4 RC48?Disitamab vedotin?
1.4 Market Analysis by Application
1.4.1 Overview: Global HER2 ADC Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospitals
1.4.3 Clinic
1.4.4 Others
1.5 Global HER2 ADC Drugs Market Size & Forecast
1.5.1 Global HER2 ADC Drugs Consumption Value (2021 & 2025 & 2032)
1.5.2 Global HER2 ADC Drugs Sales Quantity (2021-2032)
1.5.3 Global HER2 ADC Drugs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Daiichi Sankyo
2.1.1 Daiichi Sankyo Details
2.1.2 Daiichi Sankyo Major Business
2.1.3 Daiichi Sankyo HER2 ADC Drugs Product and Services
2.1.4 Daiichi Sankyo HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Daiichi Sankyo Recent Developments/Updates
2.2 Genentech, Inc.(Roche)
2.2.1 Genentech, Inc.(Roche) Details
2.2.2 Genentech, Inc.(Roche) Major Business
2.2.3 Genentech, Inc.(Roche) HER2 ADC Drugs Product and Services
2.2.4 Genentech, Inc.(Roche) HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Genentech, Inc.(Roche) Recent Developments/Updates
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca HER2 ADC Drugs Product and Services
2.3.4 AstraZeneca HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 AstraZeneca Recent Developments/Updates
2.4 RemeGen
2.4.1 RemeGen Details
2.4.2 RemeGen Major Business
2.4.3 RemeGen HER2 ADC Drugs Product and Services
2.4.4 RemeGen HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 RemeGen Recent Developments/Updates
2.5 MacroGenics
2.5.1 MacroGenics Details
2.5.2 MacroGenics Major Business
2.5.3 MacroGenics HER2 ADC Drugs Product and Services
2.5.4 MacroGenics HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 MacroGenics Recent Developments/Updates
2.6 Takeda
2.6.1 Takeda Details
2.6.2 Takeda Major Business
2.6.3 Takeda HER2 ADC Drugs Product and Services
2.6.4 Takeda HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Takeda Recent Developments/Updates
2.7 Biokin Pharmaceutical
2.7.1 Biokin Pharmaceutical Details
2.7.2 Biokin Pharmaceutical Major Business
2.7.3 Biokin Pharmaceutical HER2 ADC Drugs Product and Services
2.7.4 Biokin Pharmaceutical HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Biokin Pharmaceutical Recent Developments/Updates
2.8 BioNTech(Yingen Biopharmaceutical)
2.8.1 BioNTech(Yingen Biopharmaceutical) Details
2.8.2 BioNTech(Yingen Biopharmaceutical) Major Business
2.8.3 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product and Services
2.8.4 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 BioNTech(Yingen Biopharmaceutical) Recent Developments/Updates
2.9 CSPC Pharmaceutical Group
2.9.1 CSPC Pharmaceutical Group Details
2.9.2 CSPC Pharmaceutical Group Major Business
2.9.3 CSPC Pharmaceutical Group HER2 ADC Drugs Product and Services
2.9.4 CSPC Pharmaceutical Group HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 CSPC Pharmaceutical Group Recent Developments/Updates
2.10 Hengrui Pharmaceuticals
2.10.1 Hengrui Pharmaceuticals Details
2.10.2 Hengrui Pharmaceuticals Major Business
2.10.3 Hengrui Pharmaceuticals HER2 ADC Drugs Product and Services
2.10.4 Hengrui Pharmaceuticals HER2 ADC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Hengrui Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HER2 ADC DRUGS BY MANUFACTURER
3.1 Global HER2 ADC Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global HER2 ADC Drugs Revenue by Manufacturer (2021-2026)
3.3 Global HER2 ADC Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of HER2 ADC Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 HER2 ADC Drugs Manufacturer Market Share in 2025
3.4.3 Top 6 HER2 ADC Drugs Manufacturer Market Share in 2025
3.5 HER2 ADC Drugs Market: Overall Company Footprint Analysis
3.5.1 HER2 ADC Drugs Market: Region Footprint
3.5.2 HER2 ADC Drugs Market: Company Product Type Footprint
3.5.3 HER2 ADC Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global HER2 ADC Drugs Market Size by Region
4.1.1 Global HER2 ADC Drugs Sales Quantity by Region (2021-2032)
4.1.2 Global HER2 ADC Drugs Consumption Value by Region (2021-2032)
4.1.3 Global HER2 ADC Drugs Average Price by Region (2021-2032)
4.2 North America HER2 ADC Drugs Consumption Value (2021-2032)
4.3 Europe HER2 ADC Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific HER2 ADC Drugs Consumption Value (2021-2032)
4.5 South America HER2 ADC Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa HER2 ADC Drugs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global HER2 ADC Drugs Sales Quantity by Type (2021-2032)
5.2 Global HER2 ADC Drugs Consumption Value by Type (2021-2032)
5.3 Global HER2 ADC Drugs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global HER2 ADC Drugs Sales Quantity by Application (2021-2032)
6.2 Global HER2 ADC Drugs Consumption Value by Application (2021-2032)
6.3 Global HER2 ADC Drugs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America HER2 ADC Drugs Sales Quantity by Type (2021-2032)
7.2 North America HER2 ADC Drugs Sales Quantity by Application (2021-2032)
7.3 North America HER2 ADC Drugs Market Size by Country
7.3.1 North America HER2 ADC Drugs Sales Quantity by Country (2021-2032)
7.3.2 North America HER2 ADC Drugs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe HER2 ADC Drugs Sales Quantity by Type (2021-2032)
8.2 Europe HER2 ADC Drugs Sales Quantity by Application (2021-2032)
8.3 Europe HER2 ADC Drugs Market Size by Country
8.3.1 Europe HER2 ADC Drugs Sales Quantity by Country (2021-2032)
8.3.2 Europe HER2 ADC Drugs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific HER2 ADC Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific HER2 ADC Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific HER2 ADC Drugs Market Size by Region
9.3.1 Asia-Pacific HER2 ADC Drugs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific HER2 ADC Drugs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America HER2 ADC Drugs Sales Quantity by Type (2021-2032)
10.2 South America HER2 ADC Drugs Sales Quantity by Application (2021-2032)
10.3 South America HER2 ADC Drugs Market Size by Country
10.3.1 South America HER2 ADC Drugs Sales Quantity by Country (2021-2032)
10.3.2 South America HER2 ADC Drugs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa HER2 ADC Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa HER2 ADC Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa HER2 ADC Drugs Market Size by Country
11.3.1 Middle East & Africa HER2 ADC Drugs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa HER2 ADC Drugs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 HER2 ADC Drugs Market Drivers
12.2 HER2 ADC Drugs Market Restraints
12.3 HER2 ADC Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of HER2 ADC Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of HER2 ADC Drugs
13.3 HER2 ADC Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 HER2 ADC Drugs Typical Distributors
14.3 HER2 ADC Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global HER2 ADC Drugs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global HER2 ADC Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 4. Daiichi Sankyo Major Business
Table 5. Daiichi Sankyo HER2 ADC Drugs Product and Services
Table 6. Daiichi Sankyo HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Daiichi Sankyo Recent Developments/Updates
Table 8. Genentech, Inc.(Roche) Basic Information, Manufacturing Base and Competitors
Table 9. Genentech, Inc.(Roche) Major Business
Table 10. Genentech, Inc.(Roche) HER2 ADC Drugs Product and Services
Table 11. Genentech, Inc.(Roche) HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Genentech, Inc.(Roche) Recent Developments/Updates
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Major Business
Table 15. AstraZeneca HER2 ADC Drugs Product and Services
Table 16. AstraZeneca HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. AstraZeneca Recent Developments/Updates
Table 18. RemeGen Basic Information, Manufacturing Base and Competitors
Table 19. RemeGen Major Business
Table 20. RemeGen HER2 ADC Drugs Product and Services
Table 21. RemeGen HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. RemeGen Recent Developments/Updates
Table 23. MacroGenics Basic Information, Manufacturing Base and Competitors
Table 24. MacroGenics Major Business
Table 25. MacroGenics HER2 ADC Drugs Product and Services
Table 26. MacroGenics HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. MacroGenics Recent Developments/Updates
Table 28. Takeda Basic Information, Manufacturing Base and Competitors
Table 29. Takeda Major Business
Table 30. Takeda HER2 ADC Drugs Product and Services
Table 31. Takeda HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Takeda Recent Developments/Updates
Table 33. Biokin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Biokin Pharmaceutical Major Business
Table 35. Biokin Pharmaceutical HER2 ADC Drugs Product and Services
Table 36. Biokin Pharmaceutical HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Biokin Pharmaceutical Recent Developments/Updates
Table 38. BioNTech(Yingen Biopharmaceutical) Basic Information, Manufacturing Base and Competitors
Table 39. BioNTech(Yingen Biopharmaceutical) Major Business
Table 40. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product and Services
Table 41. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. BioNTech(Yingen Biopharmaceutical) Recent Developments/Updates
Table 43. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 44. CSPC Pharmaceutical Group Major Business
Table 45. CSPC Pharmaceutical Group HER2 ADC Drugs Product and Services
Table 46. CSPC Pharmaceutical Group HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. CSPC Pharmaceutical Group Recent Developments/Updates
Table 48. Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Hengrui Pharmaceuticals Major Business
Table 50. Hengrui Pharmaceuticals HER2 ADC Drugs Product and Services
Table 51. Hengrui Pharmaceuticals HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Hengrui Pharmaceuticals Recent Developments/Updates
Table 53. Global HER2 ADC Drugs Sales Quantity by Manufacturer (2021-2026) & (kg)
Table 54. Global HER2 ADC Drugs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 55. Global HER2 ADC Drugs Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 56. Market Position of Manufacturers in HER2 ADC Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 57. Head Office and HER2 ADC Drugs Production Site of Key Manufacturer
Table 58. HER2 ADC Drugs Market: Company Product Type Footprint
Table 59. HER2 ADC Drugs Market: Company Product Application Footprint
Table 60. HER2 ADC Drugs New Market Entrants and Barriers to Market Entry
Table 61. HER2 ADC Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global HER2 ADC Drugs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 63. Global HER2 ADC Drugs Sales Quantity by Region (2021-2026) & (kg)
Table 64. Global HER2 ADC Drugs Sales Quantity by Region (2027-2032) & (kg)
Table 65. Global HER2 ADC Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 66. Global HER2 ADC Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 67. Global HER2 ADC Drugs Average Price by Region (2021-2026) & (US$/kg)
Table 68. Global HER2 ADC Drugs Average Price by Region (2027-2032) & (US$/kg)
Table 69. Global HER2 ADC Drugs Sales Quantity by Type (2021-2026) & (kg)
Table 70. Global HER2 ADC Drugs Sales Quantity by Type (2027-2032) & (kg)
Table 71. Global HER2 ADC Drugs Consumption Value by Type (2021-2026) & (USD Million)
Table 72. Global HER2 ADC Drugs Consumption Value by Type (2027-2032) & (USD Million)
Table 73. Global HER2 ADC Drugs Average Price by Type (2021-2026) & (US$/kg)
Table 74. Global HER2 ADC Drugs Average Price by Type (2027-2032) & (US$/kg)
Table 75. Global HER2 ADC Drugs Sales Quantity by Application (2021-2026) & (kg)
Table 76. Global HER2 ADC Drugs Sales Quantity by Application (2027-2032) & (kg)
Table 77. Global HER2 ADC Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 78. Global HER2 ADC Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 79. Global HER2 ADC Drugs Average Price by Application (2021-2026) & (US$/kg)
Table 80. Global HER2 ADC Drugs Average Price by Application (2027-2032) & (US$/kg)
Table 81. North America HER2 ADC Drugs Sales Quantity by Type (2021-2026) & (kg)
Table 82. North America HER2 ADC Drugs Sales Quantity by Type (2027-2032) & (kg)
Table 83. North America HER2 ADC Drugs Sales Quantity by Application (2021-2026) & (kg)
Table 84. North America HER2 ADC Drugs Sales Quantity by Application (2027-2032) & (kg)
Table 85. North America HER2 ADC Drugs Sales Quantity by Country (2021-2026) & (kg)
Table 86. North America HER2 ADC Drugs Sales Quantity by Country (2027-2032) & (kg)
Table 87. North America HER2 ADC Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 88. North America HER2 ADC Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 89. Europe HER2 ADC Drugs Sales Quantity by Type (2021-2026) & (kg)
Table 90. Europe HER2 ADC Drugs Sales Quantity by Type (2027-2032) & (kg)
Table 91. Europe HER2 ADC Drugs Sales Quantity by Application (2021-2026) & (kg)
Table 92. Europe HER2 ADC Drugs Sales Quantity by Application (2027-2032) & (kg)
Table 93. Europe HER2 ADC Drugs Sales Quantity by Country (2021-2026) & (kg)
Table 94. Europe HER2 ADC Drugs Sales Quantity by Country (2027-2032) & (kg)
Table 95. Europe HER2 ADC Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 96. Europe HER2 ADC Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 97. Asia-Pacific HER2 ADC Drugs Sales Quantity by Type (2021-2026) & (kg)
Table 98. Asia-Pacific HER2 ADC Drugs Sales Quantity by Type (2027-2032) & (kg)
Table 99. Asia-Pacific HER2 ADC Drugs Sales Quantity by Application (2021-2026) & (kg)
Table 100. Asia-Pacific HER2 ADC Drugs Sales Quantity by Application (2027-2032) & (kg)
Table 101. Asia-Pacific HER2 ADC Drugs Sales Quantity by Region (2021-2026) & (kg)
Table 102. Asia-Pacific HER2 ADC Drugs Sales Quantity by Region (2027-2032) & (kg)
Table 103. Asia-Pacific HER2 ADC Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 104. Asia-Pacific HER2 ADC Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 105. South America HER2 ADC Drugs Sales Quantity by Type (2021-2026) & (kg)
Table 106. South America HER2 ADC Drugs Sales Quantity by Type (2027-2032) & (kg)
Table 107. South America HER2 ADC Drugs Sales Quantity by Application (2021-2026) & (kg)
Table 108. South America HER2 ADC Drugs Sales Quantity by Application (2027-2032) & (kg)
Table 109. South America HER2 ADC Drugs Sales Quantity by Country (2021-2026) & (kg)
Table 110. South America HER2 ADC Drugs Sales Quantity by Country (2027-2032) & (kg)
Table 111. South America HER2 ADC Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 112. South America HER2 ADC Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Middle East & Africa HER2 ADC Drugs Sales Quantity by Type (2021-2026) & (kg)
Table 114. Middle East & Africa HER2 ADC Drugs Sales Quantity by Type (2027-2032) & (kg)
Table 115. Middle East & Africa HER2 ADC Drugs Sales Quantity by Application (2021-2026) & (kg)
Table 116. Middle East & Africa HER2 ADC Drugs Sales Quantity by Application (2027-2032) & (kg)
Table 117. Middle East & Africa HER2 ADC Drugs Sales Quantity by Country (2021-2026) & (kg)
Table 118. Middle East & Africa HER2 ADC Drugs Sales Quantity by Country (2027-2032) & (kg)
Table 119. Middle East & Africa HER2 ADC Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 120. Middle East & Africa HER2 ADC Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 121. HER2 ADC Drugs Raw Material
Table 122. Key Manufacturers of HER2 ADC Drugs Raw Materials
Table 123. HER2 ADC Drugs Typical Distributors
Table 124. HER2 ADC Drugs Typical Customers
Table 1. Global HER2 ADC Drugs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global HER2 ADC Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 4. Daiichi Sankyo Major Business
Table 5. Daiichi Sankyo HER2 ADC Drugs Product and Services
Table 6. Daiichi Sankyo HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Daiichi Sankyo Recent Developments/Updates
Table 8. Genentech, Inc.(Roche) Basic Information, Manufacturing Base and Competitors
Table 9. Genentech, Inc.(Roche) Major Business
Table 10. Genentech, Inc.(Roche) HER2 ADC Drugs Product and Services
Table 11. Genentech, Inc.(Roche) HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Genentech, Inc.(Roche) Recent Developments/Updates
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Major Business
Table 15. AstraZeneca HER2 ADC Drugs Product and Services
Table 16. AstraZeneca HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. AstraZeneca Recent Developments/Updates
Table 18. RemeGen Basic Information, Manufacturing Base and Competitors
Table 19. RemeGen Major Business
Table 20. RemeGen HER2 ADC Drugs Product and Services
Table 21. RemeGen HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. RemeGen Recent Developments/Updates
Table 23. MacroGenics Basic Information, Manufacturing Base and Competitors
Table 24. MacroGenics Major Business
Table 25. MacroGenics HER2 ADC Drugs Product and Services
Table 26. MacroGenics HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. MacroGenics Recent Developments/Updates
Table 28. Takeda Basic Information, Manufacturing Base and Competitors
Table 29. Takeda Major Business
Table 30. Takeda HER2 ADC Drugs Product and Services
Table 31. Takeda HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Takeda Recent Developments/Updates
Table 33. Biokin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Biokin Pharmaceutical Major Business
Table 35. Biokin Pharmaceutical HER2 ADC Drugs Product and Services
Table 36. Biokin Pharmaceutical HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Biokin Pharmaceutical Recent Developments/Updates
Table 38. BioNTech(Yingen Biopharmaceutical) Basic Information, Manufacturing Base and Competitors
Table 39. BioNTech(Yingen Biopharmaceutical) Major Business
Table 40. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product and Services
Table 41. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. BioNTech(Yingen Biopharmaceutical) Recent Developments/Updates
Table 43. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 44. CSPC Pharmaceutical Group Major Business
Table 45. CSPC Pharmaceutical Group HER2 ADC Drugs Product and Services
Table 46. CSPC Pharmaceutical Group HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. CSPC Pharmaceutical Group Recent Developments/Updates
Table 48. Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Hengrui Pharmaceuticals Major Business
Table 50. Hengrui Pharmaceuticals HER2 ADC Drugs Product and Services
Table 51. Hengrui Pharmaceuticals HER2 ADC Drugs Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Hengrui Pharmaceuticals Recent Developments/Updates
Table 53. Global HER2 ADC Drugs Sales Quantity by Manufacturer (2021-2026) & (kg)
Table 54. Global HER2 ADC Drugs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 55. Global HER2 ADC Drugs Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 56. Market Position of Manufacturers in HER2 ADC Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 57. Head Office and HER2 ADC Drugs Production Site of Key Manufacturer
Table 58. HER2 ADC Drugs Market: Company Product Type Footprint
Table 59. HER2 ADC Drugs Market: Company Product Application Footprint
Table 60. HER2 ADC Drugs New Market Entrants and Barriers to Market Entry
Table 61. HER2 ADC Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global HER2 ADC Drugs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 63. Global HER2 ADC Drugs Sales Quantity by Region (2021-2026) & (kg)
Table 64. Global HER2 ADC Drugs Sales Quantity by Region (2027-2032) & (kg)
Table 65. Global HER2 ADC Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 66. Global HER2 ADC Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 67. Global HER2 ADC Drugs Average Price by Region (2021-2026) & (US$/kg)
Table 68. Global HER2 ADC Drugs Average Price by Region (2027-2032) & (US$/kg)
Table 69. Global HER2 ADC Drugs Sales Quantity by Type (2021-2026) & (kg)
Table 70. Global HER2 ADC Drugs Sales Quantity by Type (2027-2032) & (kg)
Table 71. Global HER2 ADC Drugs Consumption Value by Type (2021-2026) & (USD Million)
Table 72. Global HER2 ADC Drugs Consumption Value by Type (2027-2032) & (USD Million)
Table 73. Global HER2 ADC Drugs Average Price by Type (2021-2026) & (US$/kg)
Table 74. Global HER2 ADC Drugs Average Price by Type (2027-2032) & (US$/kg)
Table 75. Global HER2 ADC Drugs Sales Quantity by Application (2021-2026) & (kg)
Table 76. Global HER2 ADC Drugs Sales Quantity by Application (2027-2032) & (kg)
Table 77. Global HER2 ADC Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 78. Global HER2 ADC Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 79. Global HER2 ADC Drugs Average Price by Application (2021-2026) & (US$/kg)
Table 80. Global HER2 ADC Drugs Average Price by Application (2027-2032) & (US$/kg)
Table 81. North America HER2 ADC Drugs Sales Quantity by Type (2021-2026) & (kg)
Table 82. North America HER2 ADC Drugs Sales Quantity by Type (2027-2032) & (kg)
Table 83. North America HER2 ADC Drugs Sales Quantity by Application (2021-2026) & (kg)
Table 84. North America HER2 ADC Drugs Sales Quantity by Application (2027-2032) & (kg)
Table 85. North America HER2 ADC Drugs Sales Quantity by Country (2021-2026) & (kg)
Table 86. North America HER2 ADC Drugs Sales Quantity by Country (2027-2032) & (kg)
Table 87. North America HER2 ADC Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 88. North America HER2 ADC Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 89. Europe HER2 ADC Drugs Sales Quantity by Type (2021-2026) & (kg)
Table 90. Europe HER2 ADC Drugs Sales Quantity by Type (2027-2032) & (kg)
Table 91. Europe HER2 ADC Drugs Sales Quantity by Application (2021-2026) & (kg)
Table 92. Europe HER2 ADC Drugs Sales Quantity by Application (2027-2032) & (kg)
Table 93. Europe HER2 ADC Drugs Sales Quantity by Country (2021-2026) & (kg)
Table 94. Europe HER2 ADC Drugs Sales Quantity by Country (2027-2032) & (kg)
Table 95. Europe HER2 ADC Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 96. Europe HER2 ADC Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 97. Asia-Pacific HER2 ADC Drugs Sales Quantity by Type (2021-2026) & (kg)
Table 98. Asia-Pacific HER2 ADC Drugs Sales Quantity by Type (2027-2032) & (kg)
Table 99. Asia-Pacific HER2 ADC Drugs Sales Quantity by Application (2021-2026) & (kg)
Table 100. Asia-Pacific HER2 ADC Drugs Sales Quantity by Application (2027-2032) & (kg)
Table 101. Asia-Pacific HER2 ADC Drugs Sales Quantity by Region (2021-2026) & (kg)
Table 102. Asia-Pacific HER2 ADC Drugs Sales Quantity by Region (2027-2032) & (kg)
Table 103. Asia-Pacific HER2 ADC Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 104. Asia-Pacific HER2 ADC Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 105. South America HER2 ADC Drugs Sales Quantity by Type (2021-2026) & (kg)
Table 106. South America HER2 ADC Drugs Sales Quantity by Type (2027-2032) & (kg)
Table 107. South America HER2 ADC Drugs Sales Quantity by Application (2021-2026) & (kg)
Table 108. South America HER2 ADC Drugs Sales Quantity by Application (2027-2032) & (kg)
Table 109. South America HER2 ADC Drugs Sales Quantity by Country (2021-2026) & (kg)
Table 110. South America HER2 ADC Drugs Sales Quantity by Country (2027-2032) & (kg)
Table 111. South America HER2 ADC Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 112. South America HER2 ADC Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 113. Middle East & Africa HER2 ADC Drugs Sales Quantity by Type (2021-2026) & (kg)
Table 114. Middle East & Africa HER2 ADC Drugs Sales Quantity by Type (2027-2032) & (kg)
Table 115. Middle East & Africa HER2 ADC Drugs Sales Quantity by Application (2021-2026) & (kg)
Table 116. Middle East & Africa HER2 ADC Drugs Sales Quantity by Application (2027-2032) & (kg)
Table 117. Middle East & Africa HER2 ADC Drugs Sales Quantity by Country (2021-2026) & (kg)
Table 118. Middle East & Africa HER2 ADC Drugs Sales Quantity by Country (2027-2032) & (kg)
Table 119. Middle East & Africa HER2 ADC Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 120. Middle East & Africa HER2 ADC Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 121. HER2 ADC Drugs Raw Material
Table 122. Key Manufacturers of HER2 ADC Drugs Raw Materials
Table 123. HER2 ADC Drugs Typical Distributors
Table 124. HER2 ADC Drugs Typical Customers
LIST OF FIGURES
Figure 1. HER2 ADC Drugs Picture
Figure 2. Global HER2 ADC Drugs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global HER2 ADC Drugs Revenue Market Share by Type in 2025
Figure 4. T-DM1?Kadcyla?Trastuzumab emtansine? Examples
Figure 5. T-DXd?DS-8201?Enhertu?Trastuzumab deruxtecan? Examples
Figure 6. RC48?Disitamab vedotin? Examples
Figure 7. Global HER2 ADC Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Global HER2 ADC Drugs Revenue Market Share by Application in 2025
Figure 9. Hospitals Examples
Figure 10. Clinic Examples
Figure 11. Others Examples
Figure 12. Global HER2 ADC Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 13. Global HER2 ADC Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 14. Global HER2 ADC Drugs Sales Quantity (2021-2032) & (kg)
Figure 15. Global HER2 ADC Drugs Price (2021-2032) & (US$/kg)
Figure 16. Global HER2 ADC Drugs Sales Quantity Market Share by Manufacturer in 2025
Figure 17. Global HER2 ADC Drugs Revenue Market Share by Manufacturer in 2025
Figure 18. Producer Shipments of HER2 ADC Drugs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 19. Top 3 HER2 ADC Drugs Manufacturer (Revenue) Market Share in 2025
Figure 20. Top 6 HER2 ADC Drugs Manufacturer (Revenue) Market Share in 2025
Figure 21. Global HER2 ADC Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 22. Global HER2 ADC Drugs Consumption Value Market Share by Region (2021-2032)
Figure 23. North America HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 24. Europe HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 25. Asia-Pacific HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 26. South America HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 27. Middle East & Africa HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 28. Global HER2 ADC Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 29. Global HER2 ADC Drugs Consumption Value Market Share by Type (2021-2032)
Figure 30. Global HER2 ADC Drugs Average Price by Type (2021-2032) & (US$/kg)
Figure 31. Global HER2 ADC Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 32. Global HER2 ADC Drugs Revenue Market Share by Application (2021-2032)
Figure 33. Global HER2 ADC Drugs Average Price by Application (2021-2032) & (US$/kg)
Figure 34. North America HER2 ADC Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 35. North America HER2 ADC Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 36. North America HER2 ADC Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 37. North America HER2 ADC Drugs Consumption Value Market Share by Country (2021-2032)
Figure 38. United States HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 39. Canada HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 40. Mexico HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 41. Europe HER2 ADC Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 42. Europe HER2 ADC Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 43. Europe HER2 ADC Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 44. Europe HER2 ADC Drugs Consumption Value Market Share by Country (2021-2032)
Figure 45. Germany HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 46. France HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 47. United Kingdom HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 48. Russia HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 49. Italy HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 50. Asia-Pacific HER2 ADC Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 51. Asia-Pacific HER2 ADC Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 52. Asia-Pacific HER2 ADC Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 53. Asia-Pacific HER2 ADC Drugs Consumption Value Market Share by Region (2021-2032)
Figure 54. China HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 55. Japan HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 56. South Korea HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 57. India HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 58. Southeast Asia HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 59. Australia HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 60. South America HER2 ADC Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 61. South America HER2 ADC Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 62. South America HER2 ADC Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 63. South America HER2 ADC Drugs Consumption Value Market Share by Country (2021-2032)
Figure 64. Brazil HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 65. Argentina HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 66. Middle East & Africa HER2 ADC Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 67. Middle East & Africa HER2 ADC Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 68. Middle East & Africa HER2 ADC Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 69. Middle East & Africa HER2 ADC Drugs Consumption Value Market Share by Country (2021-2032)
Figure 70. Turkey HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 71. Egypt HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 72. Saudi Arabia HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 73. South Africa HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 74. HER2 ADC Drugs Market Drivers
Figure 75. HER2 ADC Drugs Market Restraints
Figure 76. HER2 ADC Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of HER2 ADC Drugs in 2025
Figure 79. Manufacturing Process Analysis of HER2 ADC Drugs
Figure 80. HER2 ADC Drugs Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. HER2 ADC Drugs Picture
Figure 2. Global HER2 ADC Drugs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global HER2 ADC Drugs Revenue Market Share by Type in 2025
Figure 4. T-DM1?Kadcyla?Trastuzumab emtansine? Examples
Figure 5. T-DXd?DS-8201?Enhertu?Trastuzumab deruxtecan? Examples
Figure 6. RC48?Disitamab vedotin? Examples
Figure 7. Global HER2 ADC Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Global HER2 ADC Drugs Revenue Market Share by Application in 2025
Figure 9. Hospitals Examples
Figure 10. Clinic Examples
Figure 11. Others Examples
Figure 12. Global HER2 ADC Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 13. Global HER2 ADC Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 14. Global HER2 ADC Drugs Sales Quantity (2021-2032) & (kg)
Figure 15. Global HER2 ADC Drugs Price (2021-2032) & (US$/kg)
Figure 16. Global HER2 ADC Drugs Sales Quantity Market Share by Manufacturer in 2025
Figure 17. Global HER2 ADC Drugs Revenue Market Share by Manufacturer in 2025
Figure 18. Producer Shipments of HER2 ADC Drugs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 19. Top 3 HER2 ADC Drugs Manufacturer (Revenue) Market Share in 2025
Figure 20. Top 6 HER2 ADC Drugs Manufacturer (Revenue) Market Share in 2025
Figure 21. Global HER2 ADC Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 22. Global HER2 ADC Drugs Consumption Value Market Share by Region (2021-2032)
Figure 23. North America HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 24. Europe HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 25. Asia-Pacific HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 26. South America HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 27. Middle East & Africa HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 28. Global HER2 ADC Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 29. Global HER2 ADC Drugs Consumption Value Market Share by Type (2021-2032)
Figure 30. Global HER2 ADC Drugs Average Price by Type (2021-2032) & (US$/kg)
Figure 31. Global HER2 ADC Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 32. Global HER2 ADC Drugs Revenue Market Share by Application (2021-2032)
Figure 33. Global HER2 ADC Drugs Average Price by Application (2021-2032) & (US$/kg)
Figure 34. North America HER2 ADC Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 35. North America HER2 ADC Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 36. North America HER2 ADC Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 37. North America HER2 ADC Drugs Consumption Value Market Share by Country (2021-2032)
Figure 38. United States HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 39. Canada HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 40. Mexico HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 41. Europe HER2 ADC Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 42. Europe HER2 ADC Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 43. Europe HER2 ADC Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 44. Europe HER2 ADC Drugs Consumption Value Market Share by Country (2021-2032)
Figure 45. Germany HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 46. France HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 47. United Kingdom HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 48. Russia HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 49. Italy HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 50. Asia-Pacific HER2 ADC Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 51. Asia-Pacific HER2 ADC Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 52. Asia-Pacific HER2 ADC Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 53. Asia-Pacific HER2 ADC Drugs Consumption Value Market Share by Region (2021-2032)
Figure 54. China HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 55. Japan HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 56. South Korea HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 57. India HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 58. Southeast Asia HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 59. Australia HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 60. South America HER2 ADC Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 61. South America HER2 ADC Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 62. South America HER2 ADC Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 63. South America HER2 ADC Drugs Consumption Value Market Share by Country (2021-2032)
Figure 64. Brazil HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 65. Argentina HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 66. Middle East & Africa HER2 ADC Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 67. Middle East & Africa HER2 ADC Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 68. Middle East & Africa HER2 ADC Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 69. Middle East & Africa HER2 ADC Drugs Consumption Value Market Share by Country (2021-2032)
Figure 70. Turkey HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 71. Egypt HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 72. Saudi Arabia HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 73. South Africa HER2 ADC Drugs Consumption Value (2021-2032) & (USD Million)
Figure 74. HER2 ADC Drugs Market Drivers
Figure 75. HER2 ADC Drugs Market Restraints
Figure 76. HER2 ADC Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of HER2 ADC Drugs in 2025
Figure 79. Manufacturing Process Analysis of HER2 ADC Drugs
Figure 80. HER2 ADC Drugs Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
